ask="N/A"
ask_size="N/A"
average_daily_volume="249095"
bid="9.06"
bid_size="200"
book_value="2.66"
change="+0.34"
change_from_200_day_moving_average="1.20"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-1.07"
change_From_52_week_low="3.00"
change_in_percent="+3.52%"
close="10.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="15511000"
high="10.00"
high_52_weeks="11.07"
last_trade_date="2/3/2017"
last_trade_price="10.00"
last_trade_size="14778"
last_trade_time="4:00pm"
low="9.67"
low_52_weeks="7.00"
market_capitalization="183.00M"
moving_average_200_day="8.80"
moving_average_50_day="9.94"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.58%"
percent_change_from_50_day_moving_average="+0.59%"
percent_change_from_52_week_high="-9.67%"
percent_change_from_52_week_low="+42.86%"
previous_close="9.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.64"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="3.69"
stock_exchange="NGM"
symbol="AKBA"
volume="95567"
weeks_range_52="7.00 - 11.07"
